Dauerman HL - Search Results

1

The effects of bivalirudin compared with those of unfractionated heparin plus eptifibatide on inflammation and thrombin generation and activity during coronary intervention.

Keating FK, Dauerman HL, Whitaker DA, Sobel BE, Schneider DJ. Keating FK, et al. Among authors: dauerman hl. Coron Artery Dis. 2005 Sep;16(6):401-5. doi: 10.1097/00019501-200509000-00010. Coron Artery Dis. 2005. PMID: 16118546 Clinical Trial.

2

Activated clotting times in the setting of eptifibatide use during percutaneous coronary intervention.

Dauerman HL, Ball SA, Goldberg RJ, Desourdy MA, Furman MI. Dauerman HL, et al. J Thromb Thrombolysis. 2002 Jun;13(3):127-32. doi: 10.1023/a:1020493705138. J Thromb Thrombolysis. 2002. PMID: 12355028 Clinical Trial.

3

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.

Aggarwal A, Schneider DJ, Terrien EF, Terrien CM Jr, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. Am J Cardiol. 2003 Jun 1;91(11):1346-9. doi: 10.1016/s0002-9149(03)00327-8. Am J Cardiol. 2003. PMID: 12767431 Clinical Trial. No abstract available.

4

Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalization.

Dauerman HL, Sobel BE. Dauerman HL, et al. J Am Coll Cardiol. 2003 Aug 20;42(4):646-51. doi: 10.1016/s0735-1097(03)00762-9. J Am Coll Cardiol. 2003. PMID: 12932595 Free article.

5

Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting.

Aggarwal A, Schneider DJ, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. Am J Cardiol. 2003 Oct 15;92(8):924-9. doi: 10.1016/s0002-9149(03)00971-8. Am J Cardiol. 2003. PMID: 14556867

6

Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response.

Aggarwal A, Schneider DJ, Terrien EF, Gilbert KE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. J Thromb Thrombolysis. 2003 Feb;15(1):25-31. doi: 10.1023/a:1026188200939. J Thromb Thrombolysis. 2003. PMID: 14574073 Clinical Trial.

7

Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques.

Aggarwal A, Schneider DJ, Terrien EF, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. Am J Cardiol. 2004 Jan 1;93(1):6-9. doi: 10.1016/j.amjcard.2003.09.003. Am J Cardiol. 2004. PMID: 14697457

8

Approaches to restenosis: mechanical and pharmacological strategies. Overview.

Dauerman HL. Dauerman HL. Coron Artery Dis. 2004 Sep;15(6):303-5. doi: 10.1097/00019501-200409000-00001. Coron Artery Dis. 2004. PMID: 15346086 Review. No abstract available.

9

Endothelial dysfunction and inflammation after percutaneous coronary intervention.

Blum A, Schneider DJ, Sobel BE, Dauerman HL. Blum A, et al. Among authors: dauerman hl. Am J Cardiol. 2004 Dec 1;94(11):1420-3. doi: 10.1016/j.amjcard.2004.07.146. Am J Cardiol. 2004. PMID: 15566916

10

Soluble CD40 ligand is an early initiator of inflammation after coronary intervention.

Aggarwal A, Blum A, Schneider DJ, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: dauerman hl. Coron Artery Dis. 2004 Dec;15(8):471-5. doi: 10.1097/00019501-200412000-00003. Coron Artery Dis. 2004. PMID: 15585987 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters